Security key
03168L105
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX)
CUSIP: 03168L105
Q1 2024 13F Holders as of 31 Mar 2024
- Security type / class
- Equity / Class A Common Stock, par value $0.01
- Total 13F shares
- 108,100,411
- Total 13F value
- $655,086,509
- Share change
- -1,078,221
- Put/Call ratio
- 25%
- SEC-reported price per share
- $6.06
- Number of holders
- 173
- Value change
- -$6,545,489
- Number of buys
- 96
- Number of sells
- 52
- Shares outstanding
- 348,532,261
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2024
Institutions
173
Top holders
10
AMRX full security history
Ownership snapshot
Full 13F holder table
Amneal Pharmaceuticals, Inc. SEC filings
Amneal Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Fosun International Ltd
Disclosed value leader
Fosun International Ltd
Comparable rows
15/15
Latest evidence
31 Dec 2023
13F
3/4/5
Lead comparable stake: 6.2%
Showing 1-6 of 15 holder rows.
Quick read
Fosun International Ltd leads the comparable SEC ownership view at 6.2%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Fosun International Ltd's linked filing trail.
Comparable ownership
Top 5
Fosun International Ltd
6.2%
VANGUARD GROUP INC
3.9%
TPG GP A, LLC
3.5%
BlackRock Finance, Inc.
2.5%
Rubric Capital Management LP
2.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Fosun International Ltd |
13F
Company
|
6.2%
|
$130,634,297
21,521,301 shares
|
— | 31 Dec 2023 |
| VANGUARD GROUP INC |
13F
Company
|
3.9%
|
$82,809,287
13,642,387 shares
|
— | 31 Dec 2023 |
| TPG GP A, LLC |
13F
3/4/5
Company · Former 10% Owner
|
3.5%
|
$74,835,616
12,328,767 shares
|
— | 31 Dec 2023 |
| BlackRock Finance, Inc. |
13F
Company
|
2.5%
|
$53,697,775
8,846,421 shares
|
— | 31 Dec 2023 |
| Rubric Capital Management LP |
13F
Company
|
2.3%
|
$48,560,000
8,000,000 shares
|
— | 31 Dec 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
1.9%
|
$39,437,336
6,497,090 shares
|
— | 31 Dec 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
173
Shares
108,100,411
Rows available
173
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2024 vs Q1 2024 Across Filers
Q1 2024 holders
173
Q1 2024 holders
173
Holder diff
0
| Investor | Q1 2024 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q1 2024 value | Value change | Value Chg % |
|---|